1. Leyva-Huerta ER, Ledesma-Montes C, RojoBotello RE, Vega-Memije E. P53 and bcl-2 immunoexpression in patients with oral lichen planus and oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal. 2012 Sep 1;17(5):e745-50. [
DOI:10.4317/medoral.18013] [
PMID] [
PMCID]
2. Sadri D, Azizi A, Farhadi S, Shokrgozar H, Entezari N. Head and neck metastatic tumors: a retrospective survey of Iranian patients. J Dent (Shiraz). 2015 Mar;16(1):17-21.
3. de Sousa FA, Paradella TC, Carvalho YR, Rosa LE. Immunohistochemical expression of PCNA, p53, bax and bcl-2 in oral lichen planus and epithelial dysplasia. J Oral Sci. 2009 Mar;51(1):117-21. [
DOI:10.2334/josnusd.51.117] [
PMID]
4. de Sousa FA, Paradella TC, Carvalho YR, Rosa LE. Comparative analysis of the expression of proliferating cell nuclear antigen, p53, bax, and bcl-2 in oral lichen planus and oral squamous cell carcinoma. Ann Diagn Pathol. 2009 Oct;13(5):308-12. [
DOI:10.1016/j.anndiagpath.2009.06.001] [
PMID]
5. Hussein MR, Al-Badaiwy ZH, Guirguis MN. Analysis of p53 and bcl-2 protein expression in the non-tumorigenic, pretumorigenic and tumorigenic keratinocytic hyperproliferative lesions. J Cutan Pathol. 2004 Nov;31(10):643-51. [
DOI:10.1111/j.0303-6987.2004.00244.x] [
PMID]
6. Shirasuna K. Oral lichen planus: Malignant potential and diagnosis. Oral Sci Int. 2014 Jan 1;11(1):1-7. [
DOI:10.1016/S1348-8643(13)00030-X]
7. Irani S, Esfahani AM, Ghorbani A. Dysplastic change rate in cases of oral lichen planus: A retrospective study of 112 cases in an Iranian population. J Oral Maxillofac Pathol. 2016 SepDec;20(3):395-399. [
DOI:10.4103/0973-029X.190911] [
PMID] [
PMCID]
8. Gonzalez-Moles MA, Galindo P, GutierrezFernandez J, Sanchez-Fernandez E, RodriguezArchilla A, Ruiz-Avila I, et al. P53 protein expression in oral squamous cell carcinoma. Survival analysis. Anticancer Res. 2001 JulAug;21(4B):2889-94.
9. van der Meij EH, Mast H, van der Waal I. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients. Oral Oncol. 2007 Sep;43(8):742-8. [
DOI:10.1016/j.oraloncology.2006.09.006] [
PMID]
10. Hsue SS, Wang WC, Chen CH, Lin CC, Chen YK, Lin LM. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. J Oral Pathol Med. 2007 Jan;36(1):25-9. [
DOI:10.1111/j.1600-0714.2006.00491.x] [
PMID]
11. Shahsavari F, Sadri D, Tabari SS. Expression of P27 Protein in Oral and Esophageal Squamous Cell Carcinoma. J Mash Dent Sch. 2012;36(3):203-10.
12. Neppelberg E, Johannessen AC, Jonsson R. Apoptosis in oral lichen planus. Eur J Oral Sci. 2001 Oct;109(5):361-4. [
DOI:10.1034/j.1600-0722.2001.00081.x] [
PMID]
13. Jordan RC, Catzavelos GC, Barrett AW, Speight PM. Differential expression of bcl2 and bax in squamous cell carcinomas of the oral cavity. Eur J Cancer B Oral Oncol. 1996 Nov;32B(6):394-400. [
DOI:10.1016/S0964-1955(96)00033-4]
14. Sargolzaei S, Farhadi S, Kazemi B, Bandehpour M, Kharazifard MJ. The correlation between p16 expression and INK4a locus mutation with grades and stages in oral squamous cell carcinoma. Indian J Pathol Microbiol. 2014 JanMar;57(1):24-30. [
DOI:10.4103/0377-4929.130877] [
PMID]
15. Dekker NP, Lozada-Nur F, Lagenaur LA, McPhail LA, Bloom CY, Regezi JA. Apoptosisassociated markers in oral lichen planus. J Oral Pathol Med. 1997 Apr;26(4):170-5. [
DOI:10.1111/j.1600-0714.1997.tb00453.x] [
PMID]
16. Al-Hashimi I, Schifter M, Lockhart PB, Wray D, Brennan M, Migliorati CA, et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Mar;103 Suppl:S25.e1-12. [
DOI:10.1016/j.tripleo.2006.11.001] [
PMID]
17. Shahsavari F, Farhadi S, Sadri D, Sedehi M. Evaluation of Microvascularity by CD34 Expression in Esophagus and Oral Squamous Cell Carcinoma. J Contemp Dent Pract. 2015 Jun 1;16(6):458-62. [
DOI:10.5005/jp-journals-10024-1706] [
PMID]
18. Rödström PO , Jontell M, Mattsson U, Holmberg E. Cancer and oral lichen planus in a Swedish population. Oral Oncol. 2004 Feb;40(2):131-8. [
DOI:10.1016/S1368-8375(03)00134-9]
19. Eisen D. The clinical features, malignant potential and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol. 2002 Feb;46(2):207-14. [
DOI:10.1067/mjd.2002.120452] [
PMID]
20. Mignogna MD, Lo Russo L, Fedele S. Gingival involvement of oral lichen planus in a series of 700 patients. J Clin Periodontol. 2005 Oct;32(10):1029-33. [
DOI:10.1111/j.1600-051X.2004.00761.x] [
PMID]
21. Wang D, Dubois RN. Prostaglandins and cancer. Gut. 2006 Jan;55(1):115-22. [
DOI:10.1136/gut.2004.047100] [
PMID] [
PMCID]
22. Farhadi S, Ghorbanpour M, Pourabed F, Lotfi A. Vascular Endothelial Growth Factor Expression in Oral Lichen Planus: A Comparative Study. J Res Dentomaxillofac Sci. 2018;3(1):1-5. [
DOI:10.29252/jrdms.3.1.1]
23. Nafarzadeh S, Jafari S, Bijani A. Assessment of bax and bcl-2 immunoexpression in patients with oral lichen planus and oral squamous cell carcinoma. Int J Mol Cell Med. 2013 Summer;2(3):136-42.
24. Stoicănescu D, Andreescu N, Belengeanu A, Meszaros N, Cornianu M. Assessment of p53 and HER-2/neu genes status and protein products in oral squamous cell carcinomas. Rom J Morphol Embryol. 2013 Jan 1;54(4):1107-13.
25. Crosthwaite N, Teale D, Franklin C, Foster GA, Stringer BM. p53 protein expression in malignant, pre-malignant and non-malignant lesions of the lip. J Clin Pathol. 1996 Aug;49(8):648-53. [
DOI:10.1136/jcp.49.8.648] [
PMID] [
PMCID]
26. Warnakulasuriya KA, Johnson NW. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions. J Oral Pathol Med. 1992 Oct;21(9):404-8. [
DOI:10.1111/j.1600-0714.1992.tb01028.x] [
PMID]
27. Schoelch ML, Le QT, Silverman S Jr, McMillan A, Dekker NP, Fu KK, et al. Apoptosisassociated proteins and the development of oral squamous cell carcinoma. Oral Oncol. 1999 Jan;35(1):77-85. [
DOI:10.1016/S1368-8375(98)00065-7]
28. Stoll C, Baretton G, Ahrens C, Löhrs U. Prognostic significance of apoptosis and associated factors in oral squamous cell carcinoma. Virchows Arch. 2000 Feb;436(2):102-8. [
DOI:10.1007/PL00008207] [
PMID]
29. Kannan K, Latha PN, Shanmugam G. Expression of bcl-2 oncoprotein in Indian oral squamous cell carcinomas. Oral Oncol. 1998 Sep;34(5):373-6. [
DOI:10.1016/S1368-8375(98)00037-2]
30. Sulkowska M, Famulski W, Chyczewski L, Sulkowski S. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity. Neoplasma. 2001;48(2):94-8.
31. Teni T, Pawar S, Sanghvi V, Saranath D. Expression of bcl-2 and bax in chewing tobaccoinduced oral cancers and oral lesions from India. Pathol Oncol Res. 2002;8(2):109-14. [
DOI:10.1007/BF03033719] [
PMID]
32. Valente G, Pagano M, Carrozzo M, Carbone M, Bobba V, Palestro G, et al. Sequential immunohistochemical p53 expression in biopsies of oral lichen planus undergoing malignant evolution. J Oral Pathol Med. 2001 Mar;30(3):135-40. [
DOI:10.1034/j.1600-0714.2001.300302.x] [
PMID]